News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,091 Results
Type
Article (14463)
Company Profile (114)
Press Release (351514)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112642)
Career Advice (456)
Deals (18613)
Drug Delivery (29)
Drug Development (31184)
Employer Resources (50)
FDA (8796)
Job Trends (7676)
News (172768)
Policy (12358)
Tag
Academia (1323)
Accelerated approval (3)
Allergies (42)
Alliances (34839)
ALS (28)
Alzheimer's disease (521)
Antibody-drug conjugate (ADC) (81)
Approvals (8830)
Artificial intelligence (258)
Autoimmune disease (5)
Automation (14)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1096)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (113)
Cell therapy (286)
Cervical cancer (11)
Clinical research (24566)
Collaboration (637)
Compensation (121)
Complete response letters (3)
COVID-19 (1148)
CRISPR (41)
C-suite (154)
Cystic fibrosis (47)
Data (1077)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4932)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38996)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51604)
Executive appointments (429)
FDA (9532)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (505)
Gene editing (94)
Generative AI (25)
Gene therapy (190)
GLP-1 (231)
Government (1235)
Grass and pollen (2)
Guidances (91)
Healthcare (9896)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1226)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8019)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (119)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (131)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (203)
MASH (16)
Medical device (11511)
Medtech (11516)
Mergers & acquisitions (10965)
Metabolic disorders (226)
Multiple sclerosis (31)
NASH (3)
Neurodegenerative disease (34)
Neuropsychiatric disorders (4)
Neuroscience (731)
NextGen: Class of 2025 (3535)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (78)
Ovarian cancer (42)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (71)
Partnered (13)
Patents (156)
Patient recruitment (60)
Peanut (26)
People (32830)
Pharmaceutical (16)
Phase I (9064)
Phase II (11084)
Phase III (7183)
Pipeline (671)
Policy (32)
Postmarket research (501)
Preclinical (4118)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (139)
Real estate (3365)
Recruiting (20)
Regulatory (9424)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (5)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (91)
Series B (56)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2509)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (328)
Venture capitalists (19)
Weight loss (35)
Women's health (18)
Worklife (2)
Date
Today (61)
Last 7 days (485)
Last 30 days (1660)
Last 365 days (16934)
2025 (6219)
2024 (18713)
2023 (22098)
2022 (30813)
2021 (32513)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24122)
Australia (4197)
California (3128)
Canada (1085)
China (260)
Colorado (175)
Connecticut (134)
Delaware (50)
Europe (49319)
Florida (518)
Georgia (142)
Idaho (33)
Illinois (295)
India (13)
Indiana (172)
Iowa (5)
Japan (126)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (484)
Massachusetts (2175)
Michigan (190)
Minnesota (265)
Mississippi (2)
Missouri (63)
Montana (24)
Nebraska (15)
Nevada (26)
New Hampshire (67)
New Jersey (971)
New Mexico (16)
New York (913)
North Carolina (553)
North Dakota (8)
Northern California (1191)
Ohio (107)
Oklahoma (11)
Oregon (20)
Pennsylvania (636)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (24)
South Dakota (1)
Southern California (1281)
Tennessee (64)
Texas (506)
United States (12322)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (42)
366,091 Results for "klox technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Klox Technologies Inc. Files a De Novo Classification Request with the U.S. Food and Drug Administration
Klox Technologies, Inc. (`Klox’), a regenerative medicine company focused on the development of its proprietary FLE biomodulation platform, today announced that it has filed a De Novo Classification Request with the US FDA for its LumiHeal System following receipt of device designation in late 2019.
February 4, 2020
·
1 min read
Deals
Klox Technologies Inc. Announces Completion of the Acquisition of FB Dermatology
Klox Technologies Inc. announced it has completed the acquisition of FB Dermatology, a specialized dermatology company commercializing Kleresca® for the treatment acne, rosacea and skin rejuvenation.
October 4, 2019
·
2 min read
Press Releases
MicroSurgical Technology (MST) Advances Leadership in Vitrectomy Technology with Presentations at ASCRS 2025 Annual Meeting
April 22, 2025
·
3 min read
Press Releases
Palatin Technologies Announces Closing of Reduced Public Offering
May 9, 2025
·
5 min read
Press Releases
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray
April 16, 2025
·
4 min read
Press Releases
BioStem Technologies to Present at the Centri Capital Conference
April 22, 2025
·
1 min read
Press Releases
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders
April 14, 2025
·
5 min read
Press Releases
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology
March 26, 2025
·
3 min read
Press Releases
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
April 30, 2025
·
1 min read
1 of 36,610
Next
